The drug Cardioton: composition, pharmacological properties, the possibilities of preventing cardiovascular diseases

DOI: https://doi.org/10.29296/25877305-2022-09-06
Download full text PDF
Issue: 
9
Year: 
2022

Professor D. Dedov, MD
Tver State Medical University
Tver Regional Clinical Cardiology Dispensary

The drug Cardioton (PARAFARM, Penza) is produced using a unique cryoprocessing technology from medicinal plants grown on the manufacturer’s own fields in ecologically clean regions of Russia. The paper reviews the data available in the literature on the antioxidant, cardioprotective, hypotensive, hypocholesterolemic, anti-inflammatory, and metabolic effects of the drug. It concludes that Cardioton can be used in the complex prevention of cardiovascular diseases in addition to the main etiotropic, pathogenetic and symptomatic therapy, by taking into account an individual approach, the severity of a condition and the comorbidity present in a particular patient.
Keywords: 
cardiology
cardiovascular diseases
prevention
Cardioton
PARAFARM company

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Kardioton: ingredients, recommended for use as follows (in Russ.). URL: https://secret-dolgolet.xyz/cardioton/
  2. Block, G., Jensen, C.D., Morrow, J.D. et al. The Effect of Vitamins C and E on Biomarkers of Oxidative Stress Depends on Baseline Level. Free Radic Biol Med. 2008; 45 (4): 377–84. DOI: 10.1016/j.freeradbiomed.2008.04.005
  3. Khatami P.G., Soleimani A., Sharifi N. et al. The effects of high-dose vitamin E supplementation on biomarkers of kidney injury, inflammation, and oxidative stress in patients with diabetic nephropathy: A randomized, double-blind, placebo-controlled trial. J Clin Lipidol. 2016; 10 (4): 922–9. DOI: 10.1016/j.jacl.2016.02.021
  4. Bishopp A., Sathyamurthy R., Manney S. et al. Biomarkers of oxidative stress and antioxidants in severe asthma: A Prospective Case-Control Study. Ann Allergy Asthma Immunol. 2017; 118 (4): 445–51. DOI: 10.1016/j.anai.2017.02.004
  5. Khabibulina M., Shamilov M. Arterial hypertension in perimenopause: effects of lisinopril and Femo-Clim combination on the hypotensive effect, functional state of endothelium, cardiac remodeling and quality of life. Vrach. 2022; 33 (2): 41–47 (in Russ.). DOI: 10.29296/25877305-2022-02-06
  6. Lazebnik L.B., Radchenko V.G., Dzhadhav S.N. et al. Systemic inflammation and non-alcoholic fatty liver disease. Experimental and Clinical Gastroenterology. 2019; 5: 29–41 (in Russ.). DOI: 10.31146/1682-8658-ecg-165-5-29-41
  7. Block G., Jensen C.D., Dalvi T.B. et al. Vitamin C treatment reduces elevated C-reactive protein. Free Radic Biol Med. 2009; 46 (1): 70–7. DOI: 10.1016/j.freeradbiomed.2008.09.030
  8. Bedhiafi T., Inchakalody V.P., Fernandes Q. et al. The potential role of vitamin C in empowering cancer immunotherapy. Biomed Pharmacother. 2022; 146: 112553. DOI: 10.1016/j.biopha.2021.112553
  9. Fouladvand F., Falahi E., Asbaghi O. et al. Effect of Vitamins C and E Co-Supplementation on Serum C-Reactive Protein Level: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Prev Nutr Food Sci. 2020; 25 (1): 1–8. DOI: 10.3746/pnf.2020.25.1.1
  10. Mah E., Matos M.D., Kawiecki D. et al. Vitamin C status is related to proinflammatory responses and impaired vascular endothelial function in healthy, college-aged lean and obese men. J Am Diet Assoc. 2011; 111 (5): 737–43. DOI: 10.1016/j.jada.2011.02.003